FDA NDC Directory · JSON-LD · Markdown

LIDOCAINE HCI AND DEXTROSE

NDC 51662-1565 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryNew Drug Application (innovator) · App NDA019830
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsDEXTROSE MONOHYDRATE (5 g/100mL)
LIDOCAINE HYDROCHLORIDE ANHYDROUS (.8 g/100mL)
Marketing started20210717
Package count1

External sources

Source: openFDA. Public-domain (CC0).